Cardiology

Doxorubicin disrupts the immune system to cause heart toxicity

Doxorubicin is a chemotherapy drug widely used in ovarian, bladder, lung, thyroid and stomach cancers, but it carries a harmful side effect. The drug causes a dose-dependent heart toxicity that can lead to congestive heart ...

Oncology & Cancer

Immune checkpoint inhibitor endocrine dysfunction explored

(HealthDay)—Patients receiving immune checkpoint inhibitor (ICI) regimens may experience endocrine dysfunction, with increased risk of thyroid dysfunction and hypophysitis for patients on combination therapy, according ...

Immunology

New insights into why the immune system fails to see cancer

Cancer hides in plain sight of the immune system. The body's natural tumor surveillance programs should be able to detect and attack rogue cancer cells when they arise, and yet when cancer thrives, it does so because these ...

Diseases, Conditions, Syndromes

WHO: Maldives, Bhutan have eliminated measles

The World Health Organization said Tuesday that Bhutan and the Maldives have eliminated measles, becoming the first countries in their region to stop the highly contagious disease.

Diseases, Conditions, Syndromes

Alternative flu vaccine should reduce medical costs and save lives

A study just published in Human Vaccines & Immunotherapeutics suggests that an alternative vaccine might bring clinical benefits and cost savings if used on a large scale when compared to the one currently in widest use.

Health

Children in the Syrian Civil War

In any conflict children are among the worst affected groups, and in the Syrian Civil War the long term health and welfare of children will be greatly impacted due to the lack of access to immunization programs, little or ...

HIV & AIDS

Mutational tug of war over HIV's disease-inducing potential

A study from Emory AIDS researchers shows how the expected disease severity when someone is newly infected by HIV reflects a balance between the virus' invisibility to the host's immune system and its ability to reproduce.

Oncology & Cancer

New insights in cancer therapy from cell death research

Researchers in the group of Prof. Dr. Peter Vandenabeele (VIB/UGent) show that killed tumour cells can serve as a potent vaccine that stimulates the immune system to prevent the outgrowth of cancer cells. This finding opens ...

Health

Researcher discusses issues with 'vaccine hesitancy'

Every now and then, a virus emerges that captures the world's attention and sparks a rush to create a vaccine to prevent its further spread: think H1N1, Ebola, and now Zika, a flu-like disease with seemingly mild effects ...

page 2 from 6